Your session is about to expire
← Back to Search
Blue Light Therapy for Raynaud's Disease
Study Summary
This trial tests whether blue light therapy can help improve the symptoms of Raynaud's phenomenon.
- Raynaud's Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 60 Patients • NCT04300010Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are geriatric individuals able to join this investigation?
"This research project is accepting participants who are above the legal age of consent and under 50 years old."
Are my qualifications sufficient for me to participate in this research endeavor?
"This clinical trial necessitates that prospective participants have raynaud disease and are aged between 18-50. There is an opening for up to 100 individuals who meet the criteria."
Are there any openings remaining in this research study?
"The evidence found on clinicaltrials.gov suggests that the recruitment period for this medical trial has concluded; The study was initially posted in August 2021 and last updated in March 2022. Despite this, there are 4 other studies actively seeking out participants at present."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger